Experimental vaginal treatment tested for early cervical abnormalities
NCT ID NCT05502367
Summary
This study tested whether a vaginal insert called ABI-2280 could safely treat precancerous cervical lesions caused by HPV. Women aged 25-55 with confirmed cervical abnormalities self-administered the treatment. Researchers measured safety, side effects, and whether the treatment reduced or eliminated the lesions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Botho ke Bontle Health Services
Waltloo, Gauteng, 0184, South Africa
-
CerviCusco
Cusco, Peru
-
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
-
Farmovs
Bloemfontein, Free State, 9301, South Africa
-
Ginobs S.A.
Lima, Peru
-
Gole Biomedical Research Centre
Ga-Mothapo, Limpopo, South Africa
-
Nafasi Integrated Solutions
Sunnyside, Gauteng, 0002, South Africa
Conditions
Explore the condition pages connected to this study.